194 related articles for article (PubMed ID: 4604153)
1. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
2. Bioavailability of drugs: principles and problems. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1973 Nov; 536():1-17. PubMed ID: 4204708
[No Abstract] [Full Text] [Related]
3. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
[TBL] [Abstract][Full Text] [Related]
4. The potential clinical significance of differences in bioavailability.
Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
[No Abstract] [Full Text] [Related]
5. Bioavailability of drugs (first of two parts).
Koch-Weser J
N Engl J Med; 1974 Aug; 291(5):233-7. PubMed ID: 4600408
[No Abstract] [Full Text] [Related]
6. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
Cabana BE
Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
[TBL] [Abstract][Full Text] [Related]
7. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
Jaminet F
J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
[No Abstract] [Full Text] [Related]
8. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Pharmacology; 1972; 8(1):102-17. PubMed ID: 4644642
[No Abstract] [Full Text] [Related]
9. [Absorption and biological availability of drugs].
Uribe M
Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
[TBL] [Abstract][Full Text] [Related]
10. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
11. Therapeutic non-equivalence.
Br Med J; 1972 Sep; 3(5827):599-600. PubMed ID: 5071688
[No Abstract] [Full Text] [Related]
12. Bioavailability and pharmacokinetic analysis of drug responding systems.
Smolen VF
Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
[No Abstract] [Full Text] [Related]
13. Proceedings: The line-up on bioavailability.
Schneller GH
Rev Can Biol; 1973; 32():Suppl:151-5. PubMed ID: 4777598
[No Abstract] [Full Text] [Related]
14. Bioavailability of peroral dosage forms.
Ritschel WA
Boll Chim Farm; 1973 Mar; 112(3):137-62. PubMed ID: 4198518
[No Abstract] [Full Text] [Related]
15. Pharmacological and therapeutic aspects of drug administration by rate-controlled drug delivery systems: steady-state pharmacology.
Urquhart J
Boll Chim Farm; 1984 Apr; 123(4):155-68. PubMed ID: 6383428
[No Abstract] [Full Text] [Related]
16. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
17. [Bioavailability, proof of efficacy and their consequences for drug legislation (author's transl)].
Schnieders B
Arzneimittelforschung; 1976; 26(1A):158-63. PubMed ID: 947195
[TBL] [Abstract][Full Text] [Related]
18. Generic equivalence and non-equivalence of drugs.
Smith RN
Lancet; 1972 Sep; 2(7776):528-30. PubMed ID: 4115582
[No Abstract] [Full Text] [Related]
19. Bioavailability and bioequivalence.
Skelly JP
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
[No Abstract] [Full Text] [Related]
20. Keeping bioavailability in perspective.
Schumacher GE
Am J Hosp Pharm; 1973 Feb; 30(2):150-4. PubMed ID: 4690469
[No Abstract] [Full Text] [Related]
[Next] [New Search]
